Correlation of myeloid‐derived suppressor cells with C‐reactive protein, ferritin and lactate dehydrogenase levels in patients with severe COVID‐19

Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity

(2021) Egle Kvedaraite et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

How Do Inflammatory Mediators, Immune Response and Air Pollution Contribute to COVID-19 Disease Severity? A Lesson to Learn

(2021) Cinzia Signorini et al.   Life-Basel

Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity

(2021) Sara Falck-Jones et al.   JOURNAL OF CLINICAL INVESTIGATION

Biomarkers in COVID-19: An Up-To-Date Review

(2021) Madhusudan Samprathi et al.   Frontiers in Pediatrics

Identification of an Immature Subset of PMN-MDSC Correlated to Response to Checkpoint Inhibitor Therapy in Patients with Metastatic Melanoma

(2021) Françoise Gondois-Rey et al.   Cancers

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

(2020) Zunyou Wu et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19

(2020) Ahmet Kursat Azkur et al.   ALLERGY

Hematological findings and complications of COVID ‐19

(2020) Evangelos Terpos et al.   AMERICAN JOURNAL OF HEMATOLOGY

Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19

(2020) Aymeric Silvin et al.   CELL

Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19)

(2020) Chiara Agrati et al.   CELL DEATH AND DIFFERENTIATION

Risk factors for Covid-19 severity and fatality: a structured literature review

(2020) Dominik Wolff et al.   INFECTION

Risk factors for severe and critically ill COVID‐19 patients: A review

(2020) Ya‐dong Gao et al.   ALLERGY

Apoptosis‐Induced T Cell Lymphopenia Is Related to COVID‐19 Severity

(2020) Ahmet Cizmecioglu et al.   JOURNAL OF MEDICAL VIROLOGY

Risk factors for severe COVID-19 in middle-aged patients without comorbidities: a multicentre retrospective study

(2020) Peng Wang et al.   Journal of Translational Medicine

Combination of Baseline LDH, Performance Status and Age as Integrated Algorithm to Identify Solid Tumor Patients with Higher Probability of Response to Anti PD-1 and PD-L1 Monoclonal Antibodies

(2019) Maria Cona et al.   Cancers

C-Reactive Protein Promotes the Expansion of Myeloid Derived Cells With Suppressor Functions

(2019) Rachel V. Jimenez et al.   Frontiers in Immunology

Clinical relevance and suppressive capacity of human MDSC subsets

(2018) Stephan Lang et al.   CLINICAL CANCER RESEARCH

Myeloid-derived suppressor cells coming of age

(2018) Filippo Veglia et al.   NATURE IMMUNOLOGY

The Role of Myeloid-Derived Suppressor Cells in Viral Infection

(2017) Megan A. O'Connor et al.   VIRAL IMMUNOLOGY

Assessment of Clinical Criteria for Sepsis

(2016) Christopher W. Seymour et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

(2016) Mervyn Singer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment

(2016) Vinit Kumar et al.   TRENDS IN IMMUNOLOGY

Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

(2016) Vincenzo Bronte et al.   Nature Communications

Polarization of Monocytic Myeloid-Derived Suppressor Cells by Hepatitis B Surface Antigen Is Mediated via ERK/IL-6/STAT3 Signaling Feedback and Restrains the Activation of T Cells in Chronic Hepatitis B Virus Infection

(2015) Zhong Fang et al.   JOURNAL OF IMMUNOLOGY

A Method for Identification and Analysis of Non-Overlapping Myeloid Immunophenotypes in Humans

(2015) Michael P. Gustafson et al.   PLoS One

Myeloid-derived suppressor cells: the dark knight or the joker in viral infections?

(2013) Celeste Goh et al.   IMMUNOLOGICAL REVIEWS

Clinical Significance and Functional Studies of Myeloid-Derived Suppressor Cells in Chronic Hepatitis C Patients

(2013) Weiping Cai et al.   JOURNAL OF CLINICAL IMMUNOLOGY

HIV Type 1 gp120–Induced Expansion of Myeloid Derived Suppressor Cells Is Dependent on Interleukin 6 and Suppresses Immunity

(2013) Ankita Garg et al.   JOURNAL OF INFECTIOUS DISEASES

Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells

(2012) T Vollbrecht et al.   Retrovirology